GREENFIELD, Ind. — The U.S. Food and Drug Administration (FDA) has approved the combination feeding of Pulmotil, an in-feed bovine respiratory disease (BRD) treatment, with Rumensin, an efficiency-enhancing feed additive manufactured by Elanco Animal Health.
Approved by the FDA in late 2011, Pulmotil (tilmicosin) is also manufactured by Elanco. It is a BRD treatment for groups of cattle in the early stages of an outbreak that provides 14 days of sustained in-feed therapy, a practice that reduces stress associated with cattle handling.
Pulmotil expands BRD control beyond the chute by providing another option for groups of cattle not requiring a metaphylaxis treatment on arrival and/or when labor resources are limited.
By feeding Pulmotil, producers can reduce pulls, while requiring less individual animal management.
Similar to the prescription requirement for injectable products, the FDA requires a veterinarian to issue a Veterinary Feed Directive (VFD) for the use of Pulmotil to help ensure veterinarian oversight and judicious use of Pulmotil according to the label use and feeding directions.
STAY INFORMED. SIGN UP!
Up-to-date agriculture news in your inbox!
